176
Participants
Start Date
March 8, 2022
Primary Completion Date
August 19, 2023
Study Completion Date
June 1, 2024
Apremilast
Oral tablets
Placebo
Oral tablets
Aichi Medical University Hospital, Nagakute-shi
Nagoya City University Hospital, Nagoya
Toho University Sakura Medical Center, Sakura-shi
Ehime University Hospital, Toon-shi
Kusuhara Dermatology Clinic, Fukuoka
Fukuoka University Hospital, Fukuoka
Higuchi Dermatology Urology Clinic, Kasuga-shi
Kurume University Hospital, Kurume-shi
Nagata Dermatology Clinic, Ogori-shi
Fukushima Medical University Hospital, Fukushima
Central Japan International Medical Center, Minokamo-shi
Motomachi Dermatology Clinic, Asahikawa-shi
Asahikawa Medical University Hospital, Asahikawa-shi
Medical corporation kojinkai Chitose dermatology and plastic surgery clinic, Chitose-shi
Shinoro Dermatology Clinic, Sapporo
Medical Corporation Kojinkai Kitago Dermatology Clinic, Sapporo
Shibaki Dermatology Clinic, Sapporo
Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo
Kobe University Hospital, Kobe
Mito Kyodo General Hospital, Mito
Ishikawa Prefectural Central Hospital, Kanazawa
Takamatsu Red Cross Hospital, Takamatsu
Kagoshima University Hospital, Kagoshima
Nomura Dermatology Clinic, Yokohama
Kochi Medical School Hospital, Nankoku-shi
Nagaoka Red Cross Hospital, Nagaoka-shi
Oita University Hospital, Yufu-shi
Nippon Life Hospital, Osaka
Medical Corporation Goto Dermatology Clinic, Osaka
Dermatology and Ophthalmology Kume Clinic, Sakai-shi
Yoshikawa Skin Clinic, Takatsuki-shi
Dokkyo Medical University Saitama Medical Center, Koshigaya-shi
Pansy Skin Clinic, Saitama-shi
Jichi Medical University Hospital, Shimotsuke-shi
Tokyo Teishin Hospital, Chiyoda-ku
Teikyo University Hospital, Itabashi-ku
Nihon University Itabashi Hospital, Itabashi-ku
Tokyo Medical University Hospital, Shinjuku-ku
Seibo International Catholic Hospital, Shinjuku-ku
Yamanashi Prefectural Central Hospital, Kofu
Lead Sponsor
Amgen
INDUSTRY